Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment

Condition:   Schizophrenics Interventions:   Drug: Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega];   Drug: Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA] Sponsor:   Calo Psychiatric Center Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials